4.8 Article

H3K27 modifiers regulate lifespan in C. elegans in a context-dependent manner

Journal

BMC BIOLOGY
Volume 19, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12915-021-00984-8

Keywords

Ageing; Lifespan; Healthspan; C; elegans; Chromatin; Histone demethylase; Histone methyltransferase; H3K27

Categories

Funding

  1. BBSRC [BB/M011224/1, BB/M006727/1]
  2. Wellcome [097305/Z/11/Z]
  3. NIH Office of Research Infrastructure Programs [P40 OD010440]
  4. Wellcome Trust [097305/Z/11/Z] Funding Source: Wellcome Trust
  5. BBSRC [BB/M011224/1, BB/M006727/1] Funding Source: UKRI

Ask authors/readers for more resources

This study identifies chromatin modifiers as key regulators of longevity, with interactions between different factors such as expression levels and tissue specificity influencing lifespan outcomes. When considering molecular and tissue-specific effects, the heterochromatin loss model of ageing may be too simplistic to fully explain organismal ageing.
BackgroundEvidence of global heterochromatin decay and aberrant gene expression in models of physiological and premature ageing have long supported the heterochromatin loss theory of ageing, which proposes that ageing is aetiologically linked to, and accompanied by, a progressive, generalised loss of repressive epigenetic signatures. However, the remarkable plasticity of chromatin conformation suggests that the re-establishment of such marks could potentially revert the transcriptomic architecture of animal cells to a younger state, promoting longevity and healthspan. To expand our understanding of the ageing process and its connection to chromatin biology, we screened an RNAi library of chromatin-associated factors for increased longevity phenotypes.ResultsWe identified the lysine demethylases jmjd-3.2 and utx-1, as well as the lysine methyltransferase mes-2 as regulators of both lifespan and healthspan in C. elegans. Strikingly, we found that both overexpression and loss of function of jmjd-3.2 and utx-1 are all associated with enhanced longevity. Furthermore, we showed that the catalytic activity of UTX-1, but not JMJD-3.2, is critical for lifespan extension in the context of overexpression. In attempting to reconcile the improved longevity associated with both loss and gain of function of utx-1, we investigated the alternative lifespan pathways and tissue specificity of longevity outcomes. We demonstrated that lifespan extension caused by loss of utx-1 function is daf-16 dependent, while overexpression effects are partially independent of daf-16. In addition, lifespan extension was observed when utx-1 was knocked down or overexpressed in neurons and intestine, whereas in the epidermis, only knockdown of utx-1 conferred improved longevity.ConclusionsWe show that the regulation of longevity by chromatin modifiers can be the result of the interaction between distinct factors, such as the level and tissue of expression. Overall, we suggest that the heterochromatin loss model of ageing may be too simplistic an explanation of organismal ageing when molecular and tissue-specific effects are taken into account.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available